These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22914677)

  • 21. An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT).
    Taniguchi Y; Sasaki S
    Org Biomol Chem; 2012 Oct; 10(41):8336-41. PubMed ID: 22987068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement and inhibition by 2'-O-hydroxyethyl residues of gene targeting mediated by triple helix forming oligonucleotides.
    Kundu M; Nagatsugi F; Majumdar A; Miller PS; Seidman MM
    Nucleosides Nucleotides Nucleic Acids; 2003 Oct; 22(10):1927-38. PubMed ID: 14609232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A bis-alkylating triplex forming oligonucleotide inhibits intracellular reporter gene expression and prevents triplex unwinding due to helicase activity.
    Ziemba AJ; Reed MW; Raney KD; Byrd AB; Ebbinghaus SW
    Biochemistry; 2003 May; 42(17):5013-24. PubMed ID: 12718544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A web-based search engine for triplex-forming oligonucleotide target sequences.
    Gaddis SS; Wu Q; Thames HD; DiGiovanni J; Walborg EF; MacLeod MC; Vasquez KM
    Oligonucleotides; 2006; 16(2):196-201. PubMed ID: 16764543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The development of bioactive triple helix-forming oligonucleotides.
    Seidman MM; Puri N; Majumdar A; Cuenoud B; Miller PS; Alam R
    Ann N Y Acad Sci; 2005 Nov; 1058():119-27. PubMed ID: 16394131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-affinity triple helix formation by synthetic oligonucleotides at a site within a selectable mammalian gene.
    Vasquez KM; Wensel TG; Hogan ME; Wilson JH
    Biochemistry; 1995 May; 34(21):7243-51. PubMed ID: 7766635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting DNA with triplex-forming oligonucleotides to modify gene sequence.
    Simon P; Cannata F; Concordet JP; Giovannangeli C
    Biochimie; 2008 Aug; 90(8):1109-16. PubMed ID: 18460344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA triple-helix formation at pyrimidine-purine inversion sites.
    Parel SP; Marfurt J; Leumann CJ
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):411-7. PubMed ID: 11563056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triple helix formation by (G,A)-containing oligonucleotides: asymmetric sequence effect.
    Arimondo PB; Barcelo F; Sun JS; Maurizot JC; Garestier T; Hélène C
    Biochemistry; 1998 Nov; 37(47):16627-35. PubMed ID: 9843430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted genome modification via triple helix formation.
    Kalish JM; Glazer PM
    Ann N Y Acad Sci; 2005 Nov; 1058():151-61. PubMed ID: 16394134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcription inhibition induced by modified triple helix-forming oligonucleotides: a quantitative assay for evaluation in cells.
    Faria M; Wood CD; White MR; Hélène C; Giovannangeli C
    J Mol Biol; 2001 Feb; 306(1):15-24. PubMed ID: 11178890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations induced at the hypoxanthine-guanine phosphoribosyltransferase locus of human T-lymphoblasts by perturbations of purine deoxyribonucleoside triphosphate pools.
    Mattano SS; Palella TD; Mitchell BS
    Cancer Res; 1990 Aug; 50(15):4566-71. PubMed ID: 2369732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell cycle modulation of gene targeting by a triple helix-forming oligonucleotide.
    Majumdar A; Puri N; Cuenoud B; Natt F; Martin P; Khorlin A; Dyatkina N; George AJ; Miller PS; Seidman MM
    J Biol Chem; 2003 Mar; 278(13):11072-7. PubMed ID: 12538585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides.
    Rogers FA; Manoharan M; Rabinovitch P; Ward DC; Glazer PM
    Nucleic Acids Res; 2004; 32(22):6595-604. PubMed ID: 15602001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Construction of a Flp "exchange cassette" contained vector and gene targeting in mouse ES cell].
    Zheng JM; Li J; Fu JL
    Sheng Wu Gong Cheng Xue Bao; 2001 Sep; 17(5):566-9. PubMed ID: 11797223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequence and pH effects of LNA-containing triple helix-forming oligonucleotides: physical chemistry, biochemistry, and modeling studies.
    Sun BW; Babu BR; Sørensen MD; Zakrzewska K; Wengel J; Sun JS
    Biochemistry; 2004 Apr; 43(14):4160-9. PubMed ID: 15065859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleosides and nucleotides. 218. Alternate-strand triple-helix formation by the 3'-3'-linked oligodeoxynucleotides using a purine motif.
    Hoshika S; Ueno Y; Matsuda A
    Bioconjug Chem; 2003; 14(3):607-13. PubMed ID: 12757386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
    Meng Q; Su T; O'Neill JP; Walker VE
    Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure and mechanism of formation of the H-y5 isomer of an intramolecular DNA triple helix.
    van Dongen MJ; Doreleijers JF; van der Marel GA; van Boom JH; Hilbers CW; Wijmenga SS
    Nat Struct Biol; 1999 Sep; 6(9):854-9. PubMed ID: 10467098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyrimidine morpholino oligonucleotides form a stable triple helix in the absence of magnesium ions.
    Lacroix L; Arimondo PB; Takasugi M; Hélène C; Mergny JL
    Biochem Biophys Res Commun; 2000 Apr; 270(2):363-9. PubMed ID: 10753631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.